On thin ice: how the quest for a billion-dollar microbe is running out of control in Earth’s last wilderness A […]

On thin ice: how the quest for a billion-dollar microbe is running out of control in Earth’s last wilderness A

Management issues challenge biotech startups This article reviews a very interesting report that basically faults the failure of biotechnology companies

Monsanto: Ready to Blossom? Shifting the focus from farm chemicals to the more lucrative gene-altered seeds hasn’t been easy, but

FDA big factor behind high US drug costs The U.S. Food and Drug Administration, with its costly and time-consuming drug

FDA Begins Push to End Drug Imports A second ‘blitz’ inspection by federal drug and customs officials of medicines imported

What To Expect From A Venture Capitalist The more important question is, ‘What can I expect out of a good

Is ImClone Out of the Woods? If the FDA approves its Erbitux anticancer treatment, as S&P expects, the biotech’s volatile

What’s in a Drug Name? Did you ever wonder at the bizarre brand names born by your favorite medicines? If

What’s in a Drug Name? Did you ever wonder at the bizarre brand names born by your favorite medicines? If